These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29455299)

  • 1. Prostate-specific membrane antigen in breast cancer: a comprehensive evaluation of expression and a case report of radionuclide therapy.
    Tolkach Y; Gevensleben H; Bundschuh R; Koyun A; Huber D; Kehrer C; Hecking T; Keyver-Paik MD; Kaiser C; Ahmadzadehfar H; Essler M; Kuhn W; Kristiansen G
    Breast Cancer Res Treat; 2018 Jun; 169(3):447-455. PubMed ID: 29455299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers.
    Wernicke AG; Varma S; Greenwood EA; Christos PJ; Chao KS; Liu H; Bander NH; Shin SJ
    APMIS; 2014 Jun; 122(6):482-9. PubMed ID: 24304465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligometastases in prostate cancer : Metabolic response in follow-up PSMA-PET-CTs after hypofractionated IGRT.
    Baumann R; Koncz M; Luetzen U; Krause F; Dunst J
    Strahlenther Onkol; 2018 Apr; 194(4):318-324. PubMed ID: 29181556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate-specific membrane antigen (PSMA) expression in breast cancer and its metastases.
    Kasoha M; Unger C; Solomayer EF; Bohle RM; Zaharia C; Khreich F; Wagenpfeil S; Juhasz-Böss I
    Clin Exp Metastasis; 2017 Dec; 34(8):479-490. PubMed ID: 29426963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of
    Siva S; Callahan J; Pryor D; Martin J; Lawrentschuk N; Hofman MS
    J Med Imaging Radiat Oncol; 2017 Jun; 61(3):372-378. PubMed ID: 28116853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Evaluation of Prostate Specific Membrane Antigen Expression in the Vasculature of Renal Tumors: Implications for Imaging Studies and Prognostic Role.
    Spatz S; Tolkach Y; Jung K; Stephan C; Busch J; Ralla B; Rabien A; Feldmann G; Brossart P; Bundschuh RA; Ahmadzadehfar H; Essler M; Toma M; Müller SC; Ellinger J; Hauser S; Kristiansen G
    J Urol; 2018 Feb; 199(2):370-377. PubMed ID: 28827104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential use of prostate specific membrane antigen (PSMA) for detecting the tumor neovasculature of brain tumors by PET imaging with
    Matsuda M; Ishikawa E; Yamamoto T; Hatano K; Joraku A; Iizumi Y; Masuda Y; Nishiyama H; Matsumura A
    J Neurooncol; 2018 Jul; 138(3):581-589. PubMed ID: 29524126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Rare Case of Omentum Invasive Prostate Cancer: Staging With PSMA PET/CT Imaging and Response to Systemic Therapy.
    Ladwa R; Gustafson S; McCaffrey E; Miles K; O'Byrne K
    Clin Nucl Med; 2017 Jun; 42(6):e311-e312. PubMed ID: 28240670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate-specific Membrane Antigen PET: Clinical Utility in Prostate Cancer, Normal Patterns, Pearls, and Pitfalls.
    Hofman MS; Hicks RJ; Maurer T; Eiber M
    Radiographics; 2018; 38(1):200-217. PubMed ID: 29320333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent Amplification and Overexpression of PSMA in Basallike Breast Cancer from Analysis of The Cancer Genome Atlas.
    Zhou W; Halder S; Herwald S; Ghijsen M; Shafi G; Uttarwar M; Rosen E; Franc B; Kishore S
    J Nucl Med; 2024 Jul; 65(7):1004-1006. PubMed ID: 38664014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritumoral/vascular expression of PSMA as a diagnostic marker in hepatic lesions.
    Chen W; Lee Z; Awadallah A; Zhou L; Xin W
    Diagn Pathol; 2020 Jul; 15(1):92. PubMed ID: 32703222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships between serum PSA levels, Gleason scores and results of 68Ga-PSMAPET/CT in patients with recurrent prostate cancer.
    Sanli Y; Kuyumcu S; Sanli O; Buyukkaya F; İribaş A; Alcin G; Darendeliler E; Ozluk Y; Yildiz SO; Turkmen C
    Ann Nucl Med; 2017 Nov; 31(9):709-717. PubMed ID: 28900854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of Prostate-specific Membrane Antigen (PSMA/FOLH1) Expression in a Genomic Database.
    Bahler CD; Johnson MM; Davicioni E; Zhang J; Cheng L; Green MA; Koch MO
    Urology; 2020 Oct; 144():117-122. PubMed ID: 32619596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current application and future perspectives of prostate specific membrane antigen PET imaging in prostate cancer.
    Ceci F; Castellucci P; Fanti S
    Q J Nucl Med Mol Imaging; 2019 Mar; 63(1):7-18. PubMed ID: 29521482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate specific membrane antigen (PSMA) ligands for diagnosis and therapy of prostate cancer.
    Barrio M; Fendler WP; Czernin J; Herrmann K
    Expert Rev Mol Diagn; 2016 Nov; 16(11):1177-1188. PubMed ID: 27679869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PSMA expression is highly homogenous in primary prostate cancer.
    Tsourlakis MC; Klein F; Kluth M; Quaas A; Graefen M; Haese A; Simon R; Sauter G; Schlomm T; Minner S
    Appl Immunohistochem Mol Morphol; 2015 Jul; 23(6):449-55. PubMed ID: 26153794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of prostate specific membrane antigen by canine hemangiosarcoma cells provides opportunity for the molecular detection of disease burdens within hemorrhagic body cavity effusions.
    Dowling M; Samuelson J; Fadl-Alla B; Pondenis HC; Byrum M; Barger AM; Fan TM
    PLoS One; 2019; 14(1):e0210297. PubMed ID: 30601866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 225Ac-PSMA-617 for PSMA-Targeted α-Radiation Therapy of Metastatic Castration-Resistant Prostate Cancer.
    Kratochwil C; Bruchertseifer F; Giesel FL; Weis M; Verburg FA; Mottaghy F; Kopka K; Apostolidis C; Haberkorn U; Morgenstern A
    J Nucl Med; 2016 Dec; 57(12):1941-1944. PubMed ID: 27390158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiolabelled PSMA PET/CT in breast cancer. A systematic review.
    Bertagna F; Albano D; Cerudelli E; Gazzilli M; Tomasini D; Bonù M; Giubbini R; Treglia G
    Nucl Med Rev Cent East Eur; 2020; 23(1):32-35. PubMed ID: 32779172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of glutamate carboxypeptidase II (GCPII) haplotypes with breast and prostate cancer risk.
    Divyya S; Naushad SM; Addlagatta A; Murthy PV; Reddy ChR; Digumarti RR; Gottumukkala SR; Subbarao SA; Kutala VK
    Gene; 2013 Mar; 516(1):76-81. PubMed ID: 23266799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.